Adial pharmaceuticals featured on multiple news broadcasts nationwide regarding the second pandemic of alcohol use disorder

Charlottesville, va., may 18, 2021 (globe newswire) -- adial pharmaceuticals, inc. (nasdaq: adil; adilw) (“adial”), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that william stilley, chief executive officer, and dr. bankole johnson, chief medical officer, have been featured on multiple news broadcasts nationwide regarding the ‘second pandemic of addiction' arising from the covid-19 pandemic.
ADIL Ratings Summary
ADIL Quant Ranking